HOOKIPA Pharma, Inc.
(NASDAQ : HOOK)

( )
HOOK After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.92%129.200.7%$1101.99m
MRKMerck & Co., Inc.
-3.80%81.310.7%$588.08m
BMYBristol-Myers Squibb Co.
2.33%54.441.4%$581.84m
ABBVAbbVie, Inc.
0.75%77.882.3%$573.23m
PFEPfizer Inc.
-0.06%36.440.9%$572.86m
LLYEli Lilly & Co.
1.94%110.001.1%$293.15m
NVSNovartis AG
0.46%86.960.2%$158.80m
RETAReata Pharmaceuticals, Inc.
-0.98%180.183.8%$128.08m
AZNAstraZeneca Plc
0.48%43.931.2%$126.14m
GSKGlaxoSmithKline Plc
-0.16%42.530.2%$96.80m
RARXRa Pharmaceuticals, Inc.
-0.11%46.200.8%$95.99m
SNYSanofi
-1.35%45.320.2%$70.27m
NVONovo Nordisk A/S
1.31%53.290.1%$63.44m
DOVADova Pharmaceuticals, Inc.
-0.64%28.140.0%$31.00m
TAKTakeda Pharmaceutical Co., Ltd.
0.11%17.550.0%$27.12m

Company Profile

HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary its arenavirus platform that is designed to reprogram the body's immune system. Its product include VaxWace, a replication-deficient viral vector; and TheraT, a replication-attenuated viral vector, are designed to induce robust antigen specific CD8+ T cells and pathogen-neutralizing antibodies. The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel Pinschewer in 2011 and is headquartered in New York, NY.